Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1621-1630 of 2873 for cancer

Edit search filters
  1. Ruxolitinib In Combination With Pemetrexed/Cisplatin In Non Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  2. A Study Of Abemaciclib (LY2835219) In Women With HR+, HER2+ Locally Advanced Or Metastatic Breast Cancer

    Rochester, MN

  3. Radiation Therapy And Docetaxel In Treating Patients With HPV-Related Oropharyngeal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Defactinib Combined With Pembrolizumab And Gemcitabine In Patients With Advanced Cancer

    Rochester, MN

  5. Impact Of Patient Education On Alcohol Use As A Risk Factor For Breast Cancer

    La Crosse, WI, Rochester, MN

  6. A Maintenance Study With Niraparib Versus Placebo In Patients With Platinum Sensitive Ovarian Cancer

    Rochester, MN

  7. DS-8201a In Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01)

    Jacksonville, FL

  8. Avatar-Directed Chemotherapy In Treating Patients With Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. Efficacy Evaluation Of TheraSphere Following Failed First Line Chemotherapy In Metastatic Colorectal Cancer

    Rochester, MN

  10. Erlotinib Hydrochloride In Preventing Liver Cancer In Patients With Cirrhosis Of The Liver Undergoing Surgery

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer